GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
Launched by STANFORD UNIVERSITY · Jun 8, 2022
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
The GOLD trial is a study designed to help families of children diagnosed with cancer by providing support and resources to reduce anxiety and build resilience. This program will take place online, making it easier for caregivers to participate from home. The goal is to understand how effective this support can be for families facing the challenges of a recent cancer diagnosis in their child.
To be eligible for this study, parents must have a child aged 0-17 who has been diagnosed with cancer within the last year. Parents should also be fluent in English and willing to participate. Children aged 8-17 are invited to join, but they need to agree to take part in the study as well. If you meet these criteria, you could expect to engage in virtual sessions that offer helpful tools and strategies to cope with the emotional impact of cancer on your family. This trial is currently looking for participants, and it aims to provide valuable insights into how families can better navigate these difficult times together.
Gender
ALL
Eligibility criteria
- • Inclusion and Exclusion Criteria: Parents
- • Inclusion
- • Child (0-17yrs) with recent (\<12 mo) cancer diagnosis
- • Fluent in English
- • Consent to research
- Exclusion:
- • Lack of proficiency in written and spoken English
- • Parent is under age 18
- • Active Suicidal Ideation
- • Child with cancer does not provide assent
- • Inclusion and Exclusion Criteria: Children
- Inclusion:
- • Recent (\<12 mo) cancer diagnosis in child
- • 8-17 Years old
- • Provides assent to participate in the study
- Exclusion:
- • Cannot read English
- • Parent is not enrolled in the study
- • Anyone who is not a caregiver of children who have been diagnosed with cancer within the past 12 months will be excluded.
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Victoria E. Cosgrove, PhD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials